Skip to main content
Log in

Quality management in (prostate) cancer care: what do European cancer control plans tell us?

  • Topic Paper
  • Published:
World Journal of Urology Aims and scope Submit manuscript

Abstract

Introduction and purpose

National cancer control plans cf. programmes (NCCPs) are policy instruments to structure, map and organise comprehensive cancer policies in a country or its region. One of their important objectives is improvement of quality in cancer care and control.

Methods

We explored several methodological papers on NCCPs and analyses on their implementation in the European Union as well as recommendations and guidelines concerning prostate cancer screening and management.

Results and discussion

Quality is still not a very common feature of NCCPs as an independent, self-standing issue. Only a handful of countries structured and implemented specific activities to monitor quality of cancer care in their policy documents. In others, quantitative approaches focusing on epidemiology and provision of care are dominant, not focusing on indicators, especially those of process and outcome. In view of that and exploring its position in a broader sense, prostate cancer is poorly represented and insufficiently addressed, in particular with respect to screening, but also in after-care and survivorship challenges.

Conclusions

Given that methodological tools on NCCPs envisage quality as a separate chapter and an overarching topic in NCCPs, the current situation shows that we are still a long way away from the goals set. Absence of structured approaches for a cancer, such as prostate cancer, in NCCPs demonstrates the lack of consistency on all phases of comprehensive control on a frequent cancer, where practices and outcomes show unacceptable variations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. World Health Organisation (2002) National cancer control programmes: policies and managerial guidelines. World Health Organisation, Geneva

    Google Scholar 

  2. World Health Organisation (2007) Cancer control: knowledge into action. World Health Organisation guide for effective programmes. Prevention (module 1). World Health Organization, Geneva

    Google Scholar 

  3. First Danish Cancer Plan from 2000: https://www.sst.dk/da/Viden/Kraeft/Kraeftplaner/Kraeftplan-I. Accessed 21 Jul 2019

  4. Department of Health: Crown Copyright (2000) The NHS Cancer plan: a plan for investment, a plan for reform. https://www.thh.nhs.uk/documents/_Departments/Cancer/NHSCancerPlan.pdf. Accessed 20 Jan 2020

  5. Ministère de santé (2002) Plan cancer 2003–2007: Mission interministérielle pour la Lutte contre le cancer. https://www.e-cancer.fr/Plan-cancer/Les-Plans-cancer-de-2003-a-2013/Le-Plan-cancer-2003-2007. Accessed 20 Jan 2020

  6. Espina C, Soerjomataram I, Forman D, Martín-Moreno JM (2018) Cancer prevention policy in the EU: Best practices are now well recognised; no reason for countries to lag behind. J Cancer Policy 18:40–51. https://doi.org/10.1016/j.jcpo.2018.09.001

    Article  PubMed  PubMed Central  Google Scholar 

  7. Advisory Committee on Cancer Prevention (2000) Recommendations on cancer screening in the European Union. Eur J Cancer 36(12):1473–1478. https://doi.org/10.1016/S0959-8049(00)00122-2

    Article  Google Scholar 

  8. Fleshner K, Carlsson SV, Roobol MJ (2017) The effect of the USPSTF PSA screening recommendation on prostate cancer incidence patterns in the USA. Nat Rev Urol 14(1):26–37. https://doi.org/10.1038/nrurol.2016.251

    Article  CAS  PubMed  Google Scholar 

  9. Senore C, Basu P, Anttila A et al (2019) Performance of colorectal cancer screening in the European Union Member States: data from the second European screening report. Gut 68:1232–1244

    Article  Google Scholar 

  10. Albreht T, Martin-Moreno JM, Jelenc M, Gorgojo L, Harris M (2015) European guide for quality national cancer control programmes. National Institute of Public Health, Ljubljana

    Google Scholar 

  11. Albreht T, Jelenc M, Gorgojo L (2013) From “on paper” to “into action”: development of National Cancer Control Programmes in the EU. In: Albreht T, Rados-Krnel S (eds) Martin-Moreno JM Boosting Innovation and Cooperation in European Cancer Control. National Institute of Health of the Republic of Slovenia and World Health Organization on behalf of the European Observatory on Health Systems and Policies, Ljubljana

    Google Scholar 

  12. Jelenc M, Albreht T, Budewig K, Fitzpatrick P, Modrzynska A, Schellevis F, Zakotnik B, Weiderpass E (2017) Policy Paper on National Cancer Control Programmes (NCCPs)/Cancer Documents in Europe. In: CANCER control joint action [Electronic source]: policy papers/[editors Antonio Federici, Giovanni Nicoletti and Marc Van den Bulcke]. El. book. National Institute of Public Health; Brussels: Scientific Institute of Public Health, Ljubljana

  13. Albreht T, Kiasuwa R, van den Bulcke M (2017). European guide on quality improvement in comprehensive cancer control [Electronic source]. National Institute of Public Health, Ljubljana: Scientific Institute of Public Health, Brussels

  14. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clin 68:394–424. https://doi.org/10.3322/caac.21492

    Article  Google Scholar 

  15. GLOBOCAN 2012 data at: https://gco.iarc.fr/today/data/pdf/fact-sheets/cancers/cancer-fact-sheets-19.pdf. Accessed 24 Jul 2019

  16. Bertuccio P, Alicandro G, Malvezzi M, Carioli G, Boffetta P, Levi F, La Vecchia C, Negri E (2019) Cancer mortality in Europe in 2015 and an overview of trends since 1990. Ann Oncol 30(8):1356–1369

    Article  CAS  Google Scholar 

  17. Gandaglia G, Albers P, Abrahamsson PA et al (2019) Structured Population-based Prostate-specific Antigen Screening for Prostate Cancer: The European Association of Urology Position in 2019. Eur Urol 76(2):142–150. https://doi.org/10.1016/j.eururo.2019.04.033

    Article  PubMed  Google Scholar 

Download references

Funding

This article was funded by Consumers, Health and Food Executive Agency (Joint Action Cancer Contro).

Author information

Authors and Affiliations

Authors

Contributions

TA protocol/project development, data collection or management, data analysis, manuscript writing/editing.

Corresponding author

Correspondence to Tit Albreht.

Ethics declarations

Conflict of interest

I have no conflict of interest in presenting the material included in this paper.

Ethical approval

This research did not involve human participants and/or animals.

Informed consent

As this research did not involve human participants, there was no need for informed consent.

Ethical considerations

This paper has not been sent for consideration to another journal and does not form part of a series of publications on the same topic (‘salami’ publication). It presents original work the author has done in reviewing the work done in the field, where he had actively participated. All the statements to other persons’ work are quoted and listed in references. There is no other reference to work produced by other persons.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Albreht, T. Quality management in (prostate) cancer care: what do European cancer control plans tell us?. World J Urol 39, 37–39 (2021). https://doi.org/10.1007/s00345-020-03258-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-020-03258-0

Keywords

Navigation